DIFFUSE REDUCTION OF MYOCARDIAL BETA-ADRENOCEPTORS IN HYPERTROPHIC CARDIOMYOPATHY - A STUDY WITH POSITRON EMISSION TOMOGRAPHY

被引:70
作者
LEFROY, DC
DESILVA, R
CHOUDHURY, L
UREN, NG
CRAKE, T
RHODES, CG
LAMMERTSMA, AA
BOYD, H
PATSALOS, PN
NIHOYANNOPOULOS, P
OAKLEY, CM
JONES, T
CAMICI, PG
机构
[1] HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,MRC,CYCLOTRON UNIT,LONDON W12 0HS,ENGLAND
[2] HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT MED CARDIOL,LONDON,ENGLAND
关键词
D O I
10.1016/0735-1097(93)90591-N
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives. This study was conducted to determine the myocardial beta-adrenoceptor density as a marker of sympathetic function in patients with hypertrophic cardiomyopathy and normal control subjects. Background. Although some cases of hypertrophic cardiomyopathy are familial with an autosomal dominant pattern of inheritance, there remains a substantial proportion of cases in which neither a family history nor genetic abnormalities can be demonstrated. Additional abnormalities, both genetic and acquired, may be important in the phenotypic expression of this condition. Clinical features of the disease and metabolic studies suggest an increased activity of the sympathetic nervous system. Methods. Eleven patients with hypertrophic cardiomyopathy, none of whom had previously received beta-blocking drugs, and eight normal control subjects underwent positron emission tomography to evaluate regional left ventricular beta-adrenoceptor density and myocardial blood how using carbon-11-labeled CGP 12177 and oxygen-15-labeled water as tracers. Plasma catecholamines were also measured. Results. Mean (+/-SD) myocardial beta-adrenoceptor density was significantly less in the hypertrophic cardiomyopathy group than in the control group (7.70 +/- 1.86 vs. 11.50 +/- 2.18 pmol/g tissue, p < 0.001). Myocardial blood flow was similar in both groups (0.91 +/- 0.22 vs. 0.91 +/- 0.21 ml/min per g, p = NS). The distribution of beta adrenoceptor density was uniform throughout the left ventricle in both groups. In the hypertrophic Cardiomyopathy group, there was no correlation between regional wall thickness and myocardial beta-adrenoceptor density, There were no significant differences in either plasma norepinephrine or epinephrine concentrations between the two groups. Conclusions. There is a diffuse reduction in myocardial beta-adrenoceptor density in patients with hypertrophic cardiomyopathy in the absence of significantly elevated circulating catecholamine concentrations. This most likely reflects downregulation of myocardial dial beta-adrenoceptors secondary to increased myocardial concentrations of norepinephrine and is consistent with the hypothesis that cardiac sympathetic drive is increased in this condition.
引用
收藏
页码:1653 / 1660
页数:8
相关论文
共 41 条
[1]   (-)-S-[H-3]CGP-12177 AND ITS USE TO DETERMINE THE RATE CONSTANTS OF UNLABELED BETA-ADRENERGIC ANTAGONISTS [J].
AFFOLTER, H ;
HERTEL, C ;
JAEGGI, K ;
PORTENIER, M ;
STAEHELIN, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1985, 82 (03) :925-929
[2]   NONINVASIVE QUANTIFICATION OF REGIONAL MYOCARDIAL BLOOD-FLOW IN CORONARY-ARTERY DISEASE WITH OXYGEN-15-LABELED CARBON-DIOXIDE INHALATION AND POSITRON EMISSION TOMOGRAPHY [J].
ARAUJO, LI ;
LAMMERTSMA, AA ;
RHODES, CG ;
MCFALLS, EO ;
IIDA, H ;
RECHAVIA, E ;
GALASSI, A ;
DESILVA, R ;
JONES, T ;
MASERI, A .
CIRCULATION, 1991, 83 (03) :875-885
[3]   METHODOLOGICAL CONSIDERATIONS IN THE DETERMINATION OF PLASMA-CATECHOLAMINES BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY WITH ELECTROCHEMICAL DETECTION [J].
BOULOUX, P ;
PERRETT, D ;
BESSER, GM .
ANNALS OF CLINICAL BIOCHEMISTRY, 1985, 22 (MAR) :194-203
[4]  
BRADY F, 1991, APPL RADIAT ISOTOPES, V42, P621
[5]   BETA-ADRENERGIC NEUROEFFECTOR ABNORMALITIES IN THE FAILING HUMAN HEART ARE PRODUCED BY LOCAL RATHER THAN SYSTEMIC MECHANISMS [J].
BRISTOW, MR ;
MINOBE, W ;
RASMUSSEN, R ;
LARRABEE, P ;
SKERL, L ;
KLEIN, JW ;
ANDERSON, FL ;
MURRAY, J ;
MESTRONI, L ;
KARWANDE, SV ;
FOWLER, M ;
GINSBURG, R .
JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (03) :803-815
[6]   DECREASED CATECHOLAMINE SENSITIVITY AND BETA-ADRENERGIC-RECEPTOR DENSITY IN FAILING HUMAN HEARTS [J].
BRISTOW, MR ;
GINSBURG, R ;
MINOBE, W ;
CUBICCIOTTI, RS ;
SAGEMAN, WS ;
LURIE, K ;
BILLINGHAM, ME ;
HARRISON, DC ;
STINSON, EB .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 307 (04) :205-211
[7]   CARDIAC NOREPINEPHRINE KINETICS IN HYPERTROPHIC CARDIOMYOPATHY [J].
BRUSH, JE ;
EISENHOFER, G ;
GARTY, M ;
STULL, R ;
MARON, BJ ;
CANNON, RO ;
PANZA, JA ;
EPSTEIN, SE ;
GOLDSTEIN, DS .
CIRCULATION, 1989, 79 (04) :836-844
[8]   CORONARY VASODILATION IS IMPAIRED IN BOTH HYPERTROPHIED AND NONHYPERTROPHIED MYOCARDIUM OF PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY - A STUDY WITH N-13 AMMONIA AND POSITRON EMISSION TOMOGRAPHY [J].
CAMICI, P ;
CHIRIATTI, G ;
LORENZONI, R ;
BELLINA, RC ;
GISTRI, R ;
ITALIANI, G ;
PARODI, O ;
SALVADORI, PA ;
NISTA, N ;
PAPI, L ;
LABBATE, A .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1991, 17 (04) :879-886
[9]   MYOCARDIAL-METABOLISM IN ISCHEMIC HEART-DISEASE - BASIC PRINCIPLES AND APPLICATION TO IMAGING BY POSITRON EMISSION TOMOGRAPHY [J].
CAMICI, P ;
FERRANNINI, E ;
OPIE, LH .
PROGRESS IN CARDIOVASCULAR DISEASES, 1989, 32 (03) :217-238
[10]   AMELIORATION OF ANGINA PECTORIS IN IDIOPATHIC HYPERTROPHIC SUBAORTIC STENOSIS WITH BETA-ADRENERGIC BLOCKADE [J].
COHEN, LS ;
BRAUNWALD, E .
CIRCULATION, 1967, 35 (05) :847-+